• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
    • Editorial Board
    • Contact
  • Issues
    • Current Issue
    • Issue Archives
  • Multimedia
  • Editor's Update
  • Advertise
  • Reprints
  • Authors & Reviewers
    • Author Instructions
    • Submission Portal
    • Reviewers

Search

EVAR found superior to open AAA repair for long-term survival in Medicare patients: Another nail in open surgery’s coffin?

  • Thu, 5/17/12 - 9:58am
  • 1524 reads
  • 0 comments

In a recent article, Jackson et al1 reported the findings from a comparison of long-term survival after open repair (OR) versus endovascular repair (EVAR) of intact AAA among Medicare beneficiaries. It was a retrospective analysis of patients aged 65 or older in the Medicare Standard Analytic File who had repair of non-ruptured AAA from 2003 to 2007. The investigators concluded that, when compared with EVAR, OR was associated with a higher risk of all-cause mortality and aneurysm-related mortality.

The study comprised 4,529 patients in total, 703 having OR and 3,826 EVAR. Mean and median follow-up times were 2.6 and 2.5 years, respectively. The primary endpoint was all-cause mortality. Secondary outcomes were also analyzed: AAA-related mortality, hospital length of stay, 1-year readmissions, redo repair, incisional hernia repair, and lower extremity amputation. Cause of death was determined from the National Death Index. The investigators reported that an unadjusted analysis showed that in OR versus EVAR, both all-cause mortality and aneurysm-specific mortality were higher for surgical treatment. After adjusting for emergency admission, age, calendar year, sex, race, and comorbidities, there was a higher risk of both all-cause mortality and AAA-related mortality after OR versus EVAR and this difference was statistically significant.

The adjusted hospital length of stay was, on average, 6.5 days longer after OR (mean, 10.4 days), compared with EVAR (mean, 3.6 days). The incidence of incisional hernia repair was higher after OR, whereas the 1-year readmission rate, repeat AAA repair, and lower extremity amputation were not significantly different.

 

Reference

  1. Jackson RS, Chang DC, Freischlag JA. Comparison of long-term survival after open vs endovascular repair of intact abdominal aortic aneurysm among Medicare beneficiaries. JAMA. 2012;307(15):1621-1628.
Bookmark/Search this post with
  • Digg
  • LinkedIn
  • Reddit
  • Facebook Like
  • Google Plus One
  • Linkedin Share Button
  • Tweet Widget
Find more blogs image description image description
Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of HMP Communications, the editorial staff, or any member of the editorial advisory board. HMP Communications is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement or approval of the products or services advertised or of their effectiveness, quality or safety. HMP Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.


Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.
  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Kimberly Sutkowski, Classified Sales Representative
    (800) 237-7285, ext. 205

Vascular Access: The VDM Clinician Blog

Anticoagulant Treatment of DVT and Preventing DVT-PE Made Easier

Frank J Criado MD FACS FSVM

Retrograde Crossing: When the Front Door Is Locked, Look for Another Way In!

Ajay U. Mhatre MD

Collecting More Data for Vascular Patients

Lawrence A. Garcia MD

A Road Less Traveled: Access in the Right Brachial Artery

Ajay U. Mhatre MD

Endovascular Options for Complex Abdominal Aortic Aneurysms

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Elixir Medical Announces 2-Year Results From EXCELLA BD Trial for DESyne BD System With Biodegradable Polymer Coating
    Fri, 05/24/13 - 11:42am
  • Covidien Releases Results From First-in-Human Study of New Drug-Coated Balloon
    Fri, 05/24/13 - 11:19am
  • Six-Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at EuroPCR Meeting in Paris
    Fri, 05/24/13 - 11:06am
  • Medtronic IN.PACT Falcon Drug-Eluting Balloon Yields Positive Outcomes in Small Coronary Arteries
    Thu, 05/23/13 - 3:30pm
more »

Clinical Events Calendar

  • EuroPCR 2013
    Tue, 05/21/2013 - Fri, 05/24/2013
    Paris, France
  • European Society for Vascular Surgery European Vascular Trauma Workshop
    Mon, 05/27/2013 - Tue, 05/28/2013
    Sweden
  • Society for Vascular Surgery Vascular Annual Meeting 2013 (SVS)
    Thu, 05/30/2013 - Sat, 06/01/2013
    San Francisco, CA, United States
more »

Poll

Drug-eluting balloons will have a major role in lower-extremity revascularization in the future.:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2013 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2013 HMP Communications